ECCOGENE Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $25.5M

  • Investors
  • 12

ECCOGENE General Information

Description

Developer of metabolism and immune-related diseases intended to treat obesity and diabetes. The company specializes in disease biology, medicinal chemistry, and translational science and aims to create molecular level immunological pharmaceuticals to treat complex chronic diseases, providing a pipeline of metabolic drugs to improve patient conditions.

Contact Information

Website
www.eccogene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 402A, No. 326 Edison Road
  • Zhangjiang Hi-Tech Park, Pudong New Area
  • Shanghai
  • China
+86 021
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Room 402A, No. 326 Edison Road
  • Zhangjiang Hi-Tech Park, Pudong New Area
  • Shanghai
  • China
+86 021

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ECCOGENE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 11-Jun-2023 $25.5M Completed Clinical Trials - Phase 1
2. Early Stage VC 22-Dec-2020 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 06-Sep-2018 $14.6M $14.6M Completed Startup
To view ECCOGENE’s complete valuation and funding history, request access »

ECCOGENE Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of metabolism and immune-related diseases intended to treat obesity and diabetes. The company specializes in d
Pharmaceuticals
Shanghai, China

Hong Kong, Hong Kong
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ECCOGENE Competitors (1)

One of ECCOGENE’s competitors is HUTCHMED, a Corporation company based in Hong Kong, Hong Kong.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HUTCHMED Corporation Hong Kong, Hong Kong
You’re viewing 1 of 1 competitors. Get the full list »

ECCOGENE Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

ECCOGENE Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220348564-A1 Phenyl-[1,3]dioxolo[4,5-c]pyridinyl-phenyl-, phenyl-[1,3]dioxolo[4,5-c]pyridinyl-heteroaryl-, or phenyl-(1,3)dioxo[4,5-c]pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo[d]imidazole-carboxylic acid derivatives and methods of using same Inactive 24-Mar-2021

ECCOGENE Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elikon Venture Venture Capital Minority
Huajin Investment Venture Capital Minority
New Alliance Capital Growth/Expansion Minority
Pine Venture Capital Venture Capital Minority
Zhangke Herun Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

ECCOGENE FAQs

  • When was ECCOGENE founded?

    ECCOGENE was founded in 2018.

  • Where is ECCOGENE headquartered?

    ECCOGENE is headquartered in Shanghai, China.

  • What industry is ECCOGENE in?

    ECCOGENE’s primary industry is Pharmaceuticals.

  • Is ECCOGENE a private or public company?

    ECCOGENE is a Private company.

  • What is the current valuation of ECCOGENE?

    The current valuation of ECCOGENE is .

  • What is ECCOGENE’s current revenue?

    The current revenue for ECCOGENE is .

  • How much funding has ECCOGENE raised over time?

    ECCOGENE has raised $55.3M.

  • Who are ECCOGENE’s investors?

    Elikon Venture, Huajin Investment, New Alliance Capital, Pine Venture Capital, and Zhangke Herun Capital are 5 of 12 investors who have invested in ECCOGENE.

  • Who are ECCOGENE’s competitors?

    HUTCHMED is a competitor of ECCOGENE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »